Skip to main
University-wide Navigation

The University of Kentucky (UK) is committed to providing a safe and productive working environment for all personnel. UK provides the following Occupational Health and Safety Program (OHSP) for all individuals working within its animal facilities who are involved in the direct care of vertebrate animals and their living quarters, as well as those individuals who have direct contact with animals, their viable tissues, body fluids or wastes. The goal of the OHSP is to prevent occupational injury and illness associated with vertebrate animal related activities. Further, the program is designed to protect the health of the vertebrate research animals from certain diseases transmissible from humans to animals as well as be pertinent to the work individuals perform and the species to which they are exposed.

The OHSP related to animal care and use also addresses regulatory mandates. The Public Health Service Policy on Humane Care and Use of Laboratory Animals (PHS Policy) and the Guide for the Care and Use of Laboratory Animals, National Academy Press, 1996 (ILAR Guide) provide guidance and regulations regarding the use of animals in biomedical research, education, and testing. The PHS Policy requires a “health program for personnel who work in laboratory animal facilities or have frequent contact with animals” and requires that institutions use the ILAR Guide “as a basis for developing and implementing an institutional program for activities involving animals.” The ILAR Guide states: “An occupational health and safety program must be part of the overall animal care and use program.” Guidelines and recommendations specifically addressing the use of agricultural animals in agricultural research and teaching are provided by the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching, American Society of Animal Science, 2020 (Ag Guide). The Ag Guide states that “An occupational health and safety program must be established for individuals who work with agricultural animals.” Lastly, the General Duty Clause of the Occupational Safety and Health Administration (OSHA) regulations requires that the employer provide employees with “employment and a place of employment which are free from recognized hazards that are causing or are likely to cause death or serious physical harm.” [29 CFR Part 1910, 5(a)(1)]

Participation Requirements

PARTICIPATION REQUIREMENTS

Participation in the OHSP is based on having contact (direct OR indirect) with live vertebrate animals and/or potential exposure to hazardous agents associated with such animals. The OHSP is applicable to the following personnel:

  • Full-time, part-time, and temporary personnel involved in animal care in UK units that house animals for research and teaching.
  • Research investigators and their technical/research staff involved with animal work (includes post-docs, graduate students and undergraduate students).
  • Instructors involved with animal related work.
  • Other UK personnel who may be reasonably expected to come in contact with vertebrate animals, their viable tissues, body fluids or wastes (some personnel in facilities management, security, custodial services and safety/oversight such as EHS personnel and individuals conducting IACUC facility inspections).

The Institutional Animal Care and Use Committee (IACUC) staff works in association with the medical personnel in charge of administering the OHSP to identify and notify those personnel required to participate in the OHSP.

Administrative Procedures

ADMINISTRATIVE PROCEDURES

Hazard identification and risk assessment are a cooperative effort involving the Medical personnel who administer the OHSP, the Institutional Biosafety Committee (IBC), the Radiation Safety Committee (RSC), the IACUC, Environmental Health and Safety (EHS), the Attending Veterinarian, the Division of Laboratory Animal Resources (DLAR) Director, and the scientists conducting animal research.

Any anticipated possession and use of infectious or potentially infectious microorganisms, hazardous biological materials and/or recombinant or synthetic nucleic acid containing material are subject to review and approval by the IBC. Any anticipated possession and use of non-exempt quantities of radioactive material are subject to review and approval by the RSC. Any anticipated possession and use of hazardous chemicals are subject to review and approval by EHS. Each entity stipulates the required control mechanisms, PPE, waste disposition, and training requirements. EHS has standing membership on each of these oversight committees. As an element of its IACUC protocol review, EHS confirms approvals from these oversight entities.

All animal care and use protocols submitted to the IACUC are reviewed by the EHS Animal Research Compliance Manager. The Animal Research Compliance Manager is the conduit to help ensure the appropriate language is incorporated into the IACUC protocol commensurate with stipulations from the safety entities. 

The Executive Director of EHS has standing membership on the IACUC and serves as the liaison to the IACUC on all matters related to environmental health and safety, as well as those identified by the aforementioned oversight committees that impact affected personnel participating in the OHSP. This includes all personnel listed in all animal care and use protocols. Approval by the IACUC for any animal care and use protocol is contingent upon prior approval by EHS and the aforementioned committees.

Medical personnel associated with the UK University Health Service (UHS) administer the OHSP program related to animal care and use. Medical Surveillance is initiated for those personnel identified as required to participate in the OHSP. The following steps are initiated by the affected personnel for participation in the OHSP.

Initial Review

Completion and submission to UHS of the “Newly Hired Animal Handler or Related Work, Intake Form” as well as the “Mandatory Animal Handler Allergy and Medical Surveillance Form.” These forms, together, request pertinent information regarding the risks of the work/exposure. The process inserts the enrollee into the occupational health and safety program database. In addition, based upon the answers provided on the forms, the OHSP medical personnel may contact the enrollee to request a meeting to evaluate and discuss a relevant issue(s).

The system also assigns reading materials which provide important information about inherent risks and issues of concern related to the animal environment to include animal allergies and relevant zoonotic diseases.

  1. UHS medical personnel conducts a clinical review based on the information provided on the aforementioned forms. They will determine if no further action is required, more information is required, or an evaluation is required by a Licensed Healthcare Professional to include any recommended or required immunizations and/or medical screening. In so doing, individuals are placed in one of three categories of participation.
  2. Once the affected individual has been cleared by the OHSP medical personnel to have contact with live vertebrates and potential exposure to hazardous agents, they may begin work with live vertebrates.

Annual Review

Auto reminders are in place for annual enrollment updates to the “Mandatory Animal Handler Allergy and Medical Surveillance Form.” At this time, the OHSP medical personnel will conduct a review of the updated Surveillance Form in determining if any changes have occurred to the individual’s health and exposure profile to include a change in species. Should a change in species have occurred, the individual is also instructed to complete the “Change in Animal Handler Species, Protection Re-evaluation Form.” 

IACUC Protocol Amendment Review

Any amendment to an animal protocol that indicates the addition of nonhuman primates, ruminants, cats, and/or animals in the wild to the list of species to which one has exposure triggers an alert to the program participant(s) by an IACUC staff member of the need for the individual to complete the “Change in Animal Handler Species, Protection Re-evaluation Form” for review by the medical personnel so that the prescribed program requirements and/or recommendations are implemented. 

Minors

Minors under the age of 14 are not permitted inside of any research laboratory, greenhouse, or animal facility at UK unless it is for UK sponsored programs which are designed for youth under the age of 14 and which have documented training and safety policies. Due to the short duration of the activity, minors are typically not enrolled in the OHSP, however, UK has established and implemented a Safety of Minors in Research Program that accounts for minors in animal facilities. This policy requires that a risk assessment be conducted of all planned tasks and specifies all personal protective equipment (PPE) and training requirements that must be implemented to allow for minors to participate in any sponsored programs involving animals. UHS Consent for Treatment of Minor form

Occupational Healthcare Services

Components of the OHSP for Category 1 Participants

Category 1 participants

Those who anticipate having direct (hands-on) or indirect (environmental/facility only) contact with rodents, rabbits, ferrets, birds, dogs, cats, agricultural animals (whether used for agricultural or biomedical research), fish, amphibians, reptiles, and/or their tissues, body fluids, or wastes.

Influenza Vaccination (required for those working with ferrets) 

Participants having contact with ferrets are required to maintain a current (annual) influenza immunization status. Ferrets are very susceptible to infection with the same strains of influenza which infect humans, and an influenza vaccination is not available for ferrets. Thus, humans are vaccinated to protect the general health of the ferrets and to safeguard the studies involving ferrets (influenza infection of such ferrets serves as a confound to the study).  

Q Fever Risk Assessment (required for those working with ruminants)

Participants having contact with sheep, goats, and cattle are at risk of contracting Q fever (Coxiella burnetti). At the time of the initial enrollment in the occupational health program participants will be assessed for their likelihood of developing chronic sequelae should they acquire Q fever. Participants with valvular or congenital heart defects, vascular grafts, liver disease, pregnancy, or those taking immunosuppressant drugs will be advised of the potential risks involved.

Tetanus Vaccination (recommended for work with all species)

Tetanus is caused by a toxin produced by bacteria that is frequently found on surfaces contaminated by dirt and/or feces of some animals. The organism can gain entrance into the body through bite wounds, puncture wounds caused by sharp objects, or contamination of other deep wounds. Failure to be immunized against tetanus could result in severe illness or death.

Immunization with tetanus toxoid (Td) is updated according to recommendations of the Advisory Committee of Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC). Booster doses may be administered during any of the following:

  • 10-year booster of routine vaccination
  • Following the report of an injury
  • As needed

Toxoplasma Screening (required for work with cats based upon risk assessment)

Participants having contact with cats or their feces may be at risk for contracting Toxoplasmosis (Toxoplasma gondii); such participants that are immunosuppressed or are female employees of childbearing capacity will be counseled regarding their susceptibility, and a Toxoplasma antibody titer will be required.

Protocol-Specific Hazards

The use of hazardous materials, such as radioisotopes, toxic chemicals, biological agents, etc. in animals is allowed only after a thorough review by the Institutional Animal Care and Use Committee (IACUC), Environmental Health and Safety (EHS), Radiation Safety Committee (RSC), and/or the Institutional Biosafety Committee (IBC), as appropriate, with subsequent provisions being established which must be followed.

Species-Specific Zoonoses Training

Provided as assigned reading as a component of the OHSP. Attestation that educational material was read is required.
 

Components of the OHSP for Category 2 Participants

Category 2 participants

Those who anticipate having direct (hands-on) or indirect (environmental/facility only) contact with nonhuman primates and/or their tissues, body fluids, or wastes.

Measles Vaccination or Proof of Immunity (required for work with NHPs)

Measles is a zoonotic disease that is very pathogenic in nonhuman primates, often causing a fatal pneumonia. Humans are the primary source of infection for nonhuman primates. Participation in the measles program is mandatory for the protection of the nonhuman primate colonies.

Tuberculosis screening (required for work with NHPs)

Tuberculosis is a zoonotic disease that can be devastating in any nonhuman primate colony. Humans are the primary source of infection for nonhuman primates. Due to the inherent risks, special precautions must be taken for those individuals working with nonhuman primates. Participation in the Tb screening program is mandatory for the protection of the nonhuman primate colonies.

Hepatitis A Vaccination (recommended for work with NHPs)

Participants who may have occupational exposure to human or nonhuman primate (NHP) fecal material or fecal-contaminated materials while working on animal research will be offered the Hepatitis A vaccination. Failure to be vaccinated against Hepatitis A virus could result in severe illness such as liver disease. Humans are the primary source of infection for nonhuman primates. The vaccine is safe and effective in protecting the individual against the potentially deadly virus.

Hepatitis B Vaccination (recommended for work with NHPs)

Participants who may have occupational exposure to human or nonhuman primate (NHP) blood, tissue, or other potentially infectious materials while working on animal research, will be offered the Hepatitis B vaccination. Failure to be vaccinated against Hepatitis B virus could result in severe illness such as liver disease. Humans are the primary source of infection for nonhuman primates. The vaccine is safe and effective in protecting the individual against the deadly virus. If declined, the employee must sign an OSHA compliant declination form that will be kept within their employee health record.

Tetanus Vaccination (recommended for work with all species)

Tetanus is caused by a toxin produced by bacteria that is frequently found on surfaces contaminated by dirt and/or the feces of some animals. The organism can gain entrance into the body through bite wounds, puncture wounds caused by sharp objects, or contamination of other deep wounds. Failure to be immunized against tetanus could result in severe illness or death.

Immunization with tetanus toxoid (Td) is updated according to recommendations of the Advisory Committee of Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC). Booster doses may be administered during any of the following:

  • 10-year booster of routine vaccination
  • Following the report of an injury
  • As needed
Protocol-Specific Hazards

The use of hazardous materials, such as radioisotopes, toxic chemicals, biological agents, etc. in animals is allowed only after a thorough review by the Institutional Animal Care and Use Committee (IACUC), Environmental Health and Safety (EHS), Radiation Safety Committee (RSC), and/or the Institutional Biosafety Committee (IBC), as appropriate, with subsequent provisions being established which must be followed. 

Species-Specific Zoonoses Training

Provided as assigned reading as a component of the OHSP. Attestation that educational material was read is required.
 

Components of the OHSP for Category 3 Participants

Category 3 participants 

Those who anticipate having direct (hands-on) or indirect (environmental/facility only) contact with animals in the wild and/or their tissues, body fluids, or wastes.

Rabies Vaccination or Proof of Immunity (recommended for work with animals in the wild based upon risk assessment)

Rabies is caused by a virus which can infect almost any mammal. The primary source of infection in people is unvaccinated dogs and animals in the wild. Transmission is through contact with saliva, mucus membranes, or blood (e.g., bite or saliva on an open wound). Rabies in unvaccinated people is almost invariably fatal without proper treatment. Immunity requires completion of the series and interval boost doses.

Tetanus Vaccination (recommended for work with all species)

Tetanus is caused by a toxin produced by bacteria that is frequently found on surfaces contaminated by dirt and/or the feces of some animals. The organism can gain entrance into the body through bite wounds, puncture wounds caused by sharp objects, or contamination of other deep wounds. Failure to be immunized against tetanus could result in severe illness or death.

Immunization with tetanus toxoid (Td) is updated according to recommendations of the Advisory Committee of Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC). Booster doses may be administered during any of the following:

  • 10-year booster of routine vaccination
  • Following the report of an injury
  • As needed
Protocol-Specific Hazards

The use of hazardous materials, such as radioisotopes, toxic chemicals, biological agents, etc. in animals is allowed only after a thorough review by the Institutional Animal Care and Use Committee (IACUC), Environmental Health and Safety (EHS), Radiation Safety Committee (RSC), and/or the Institutional Biosafety Committee (IBC), as appropriate, with subsequent provisions being established which must be followed. 

Species-Specific Zoonoses Training

Provided as assigned reading as a component of the OHSP. Attestation that educational material was read is required.

Measles Vaccination or Proof of Immunity Program

Applicable program participants (those working with NHPs) must provide evidence of measles immunity or be vaccinated with measles during their initial enrollment in the OHSP.

  1. Proof of immunity requires either:
    1. written documentation of immunization with at least two doses of live measles vaccine with the last dose given on or after their first birthday 
    2.  documented laboratory evidence of measles immunity 
    3. a physician diagnosis of disease or 
    4. birth before 1957.
  2. Personnel without evidence of measles immunity may fulfill the requirement either through undergoing a laboratory titer determination or by receiving a vaccine containing measles (usually an MMR-measles, mumps, and rubella).

Tuberculosis Screening Program 

Tuberculosis screening occurs during the initial enrollment in the OHSP and annually thereafter. Applicable program participants (those working with NHPs) will be evaluated for tuberculosis.

  1. If the employee has a history of a previous positive tuberculin skin test (TST), further skin testing is not performed.
    1. Employees with a history of a previous positive TST will be evaluated by the occupational health professional for the likelihood of active tuberculosis. If the employee history suggests the presence of active tuberculosis OR the employee cannot provide documentation of a normal chest radiograph following the discovery of the positive TST, a chest radiograph will be obtained and evaluated for active tuberculosis.
    2. A chest radiograph will also be obtained and evaluated if the employee received inappropriate chemoprophylaxis or treatment for active tuberculosis.
    3. If there is clinical or radiographic evidence of active pulmonary tuberculosis, the employee is restricted from returning to work. This restriction is not removed until the individual either provides documentation establishing that the clinical or radiographic findings can reasonably be attributed to a condition other than active pulmonary tuberculosis or the individual is appropriately treated by their personal physician to preclude to possibility of active transmission of tuberculosis. No worker will be cleared to return to the workplace until the occupational health physician is confident that the individual does not represent a health risk to others.
  2. Employees with no history of a previous positive tuberculin skin test (TST) receive tuberculin testing during enrollment in the OHSP. The initial tuberculin testing will consist of the two-step tuberculin skin testing (TST) using intradermally injected purified protein derivative (Mantoux method). Alternatively, an FDA-approved Blood Assay for Mycobacterium tuberculosis (BAMT) such as the QuantiFERON®-TB Gold test (Cellestis Limited, Carnegie, Victoria, Australia) may be used.

    Tuberculin skin test reactions must be read between 48 and 72 hours of administration by the occupational health professional or a trained designee. Evaluation of the TST will follow the CDC recommendations published in “Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005”, MMWR 54(RR-17), December 30, 2005. Indurations ≥10 mm will be considered positive in all cases while indurations ≥5 mm in patients with a baseline TST of 0 mm and known exposure.

    1. If the initial TST is positive, a medical history is obtained for symptoms suggestive of active pulmonary tuberculosis and a chest radiograph is obtained.
      1. If the individual did not have a documented negative TST in the preceding 24 months (e.g., the test result does not represent a tuberculin skin test conversion) and there is neither clinical nor radiographic evidence of active pulmonary tuberculosis, the employee is counseled, referred for further care as indicated and cleared for duty.
      2. If the worker had a documented negative TST in the preceding 24 months and is now TST reactive (e.g., a converter), the employee is restricted from work until appropriate medical treatment has been received for at least three days. The employee will be referred to his/her personal health care provider for prophylaxis.
    2. If the initial TST is negative and the second test is positive, the response is indicative of a prior infection (booster phenomenon, amnesic response). A medical history is obtained from the employee and a chest radiograph is obtained.
      1. If there is neither clinical nor radiographic evidence of active pulmonary tuberculosis, the employee is counseled, referred for further care as indicated and cleared for duty.
      2. If there is clinical or radiographic evidence of active pulmonary tuberculosis, the employee is restricted from returning to work. This restriction is not removed until the individual either provides documentation establishing that the clinical or radiographic findings can reasonably be attributed to a condition other than active pulmonary tuberculosis or the individual is appropriately treated by their personal physician to preclude the possibility of active transmission of tuberculosis. No worker will be cleared to return to the workplace until the occupational health physician is confident that the individual does not represent a health risk to others.
    3. If both of the TSTs are negative and there are no other medical contraindications, the employee is cleared for work.
  3. Tuberculin testing surveillance will be performed annually using intradermally injected purified protein derivative (PPD) (Mantoux method) for all personnel without a prior history of a reactive tuberculin test. Alternately, an FDA-approved Blood Assay for Mycobacterium tuberculosis (BAMT) such as the QuantiFERON®-TB Gold test (Cellestis Limited, Carnegie, Victoria, Australia) may be used.

    Tuberculin skin test reactions must be read between 48 and 72 hours of administration by the occupational health professional or a trained designee. Evaluation of the TST will follow the CDC recommendations published in “Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005”, MMWR 54(RR-17), December 30, 2005. Indurations ≥10 mm will be considered positive in all cases while indurations ≥5 mm in patients with a baseline TST of 0mm and known exposure.

  4. Workers converting from TST negative to TST positive will be immediately restricted from work. Personnel will be referred to their personal health care provider for further evaluation and prophylaxis treatment, as needed. The employee is restricted from work until appropriate medical treatment has been received for at least three days to preclude to possibility of transmission. Employees will not be cleared to return to the workplace until the occupational health physician is confident that the individual does not represent a health risk to others.

Workers with negative annual TST reactions will be immediately cleared for work if there are no other medical contraindications.

For reference, the Animal Handler Guarantee of Payment form may be used to assist with completion of the Medical Surveillance form in MyChart.

Selected Hazards and Preventive Measures

SELECTED HAZARDS AND PREVENTATIVE MEASURES 

A variety of occupational health risks are associated with exposure to animals used in agricultural and biomedical research and education. These risks vary from the physical risks of chemical exposures, bruises, bites, kicks, scratches, ergonomic injuries, etc. to chemical exposure risks to infectious disease risks including those from zoonotic diseases (diseases transmitted from animals to humans) and experimentally induced diseases. The risk to individuals working with animals is related to the length and type of exposure, the species involved, and health status of the individual. Minimizing the risk to individuals involves specific design features of the facility, proper operating procedures, training, personal protective equipment, personal hygiene, vaccinations and an effective monitoring system. 

Allergies 

Among the most common occupational hazards associated with working with laboratory animals is the development of allergies. The prevalence of allergies in animal-care workers has been estimated from 10% to 44% while it is estimated that nearly 10% of all personnel working with laboratory animals will develop occupational asthma. 

Several studies have suggested that persons with pre-existing allergic conditions, such as hay fever, are more likely to develop allergies to laboratory animals. While nearly 90% of personnel without any history of allergic reactions never develop allergies to laboratory animals, up to 73% of personnel with pre-existing allergic disease will develop allergies.

Most workers who develop allergic reactions to laboratory animals will do so within the first twelve months of working with them. Infrequently, reactions only occur after working with animals for several years. The initial symptoms are usually a running nose, nasal irritation, itchy eyes, and sometimes, rashes or urticaria (hives). Initially, the symptoms are present within minutes of the worker’s exposure to the animals. Approximately half of allergic workers will have their initial symptoms subside and then recur three or four hours following exposure. Approximately 10% of those developing this allergic rhinitis will eventually progress, with repeated exposure, to occupational asthma, which can result in chronic pulmonary disease even years after the exposure ceases.

Species   Allergen   Source of Allergen  Relative Risk 
Rats   Rat n 1A, Rat n 1B  Urine   +++++  
Mice   Mus m1  Urine   ++++  
Guinea Pigs  -   Urine, dander, fur, saliva  ++  
Gerbils   -   -   +  
Rabbits   Glycoprotein   Fur, saliva, urine  +++  
Cats   Fel d 1  Sebaceous glands, saliva  +++  
Dogs   Can f 1  Saliva, hair, skin  ++  
Nonhuman Primates  -   Dander   +  
Pigs   -   Urine   +  
Sheep   -   Lanolin?   +  
Birds   Protein   Feces, serum  +  

The best method to minimize the potential for the development of allergies is to minimize exposure to the allergens. Ideally, this is accomplished by limiting the chances that workers will inhale or have skin contact with animal proteins. In addition to using well-designed air handling and waste management systems in research areas, workers can reduce their risk of exposure by routinely using dust/mist masks, gloves and gowns. If additional respiratory protection is required, the worker should contact Environmental Health and Safety. 

Laboratory animal facilities are designed with relatively high air flow requirements, which reduce the concentration of allergens in the air by dilution. The control of the relative humidity to 40-70% also reduces the level of allergens in these rooms. Further allergen reduction is accomplished using individually ventilated caging (IVC) with the exhaust air passed through high efficiency particulate air filters (HEPA) to remove particulates and allergens. Animals removed from the laboratory animal facility to investigator laboratories are placed in environments which permit a much greater accumulation of allergens, potentially exposing personnel, including those not involved in the project, to higher levels of allergens. Holding soiled animal cages in the laboratory instead of immediately returning the cages to the animal facility for cleaning further increases exposure of personnel. 

The greatest risk of exposure involves any activity that disturbs the bedding material of the animal generating airborne particles. Movement of the animals within the cage, whether normal activity or during manipulations, increases personnel exposure. Exposure can be minimized by the use of specialized bedding materials or, most effectively, by the use of containment caging such as microisolators, IVC’s, or filter tops. The use of personal protective equipment can also minimize exposure. Standard surgical masks are not effective although commercial dust respirators (N95) can significantly reduce exposure. Handling the cages and animals in laminar flow or biological safety cabinets can dramatically reduce the exposure of personnel. 

If present at the time of hire, personnel with known allergies to laboratory animals should be evaluated by a physician through their personal insurance and reevaluated on a schedule determined by their physician based upon the clinical signs and symptoms. Pulmonary function tests should be performed to assess the severity of the disease and the progression, if indicated. Medical therapy may be prescribed to reduce or prevent the development of allergic symptoms. If symptoms of dermatologic or respiratory allergy and/or asthma develop during the course of employment, the employee shall file an incident report and a Workers’ Compensation claim through the employer’s insurance company. The Workers’ Compensation claims adjuster will determine where the employee shall go for evaluation and treatment. In all cases, however, exposure reduction and avoidance measures should be instituted. At a minimum, personnel with documented laboratory animal allergies should use a dust-mist respirator certified by the National Institute for Occupation Safety and Health (NIOSH). The Division of Environmental Health and Safety provides assistance in the choice of appropriate respirators and fit-testing when necessary. An alternative to the dust-mist respirator are the filtered airhood devices (Airstream Dustmaster® hood, Racal, Middlesex, UK or Bullard® PA30 Series Air-Purifying Respirator System) which have been shown to be very effective in allergen exposure reduction with increased operator comfort in certain situations.

Anaphylaxis is, fortunately, rare with laboratory animal allergies. Anaphylaxis may, however, occur in allergic personnel following an animal bite or puncture wound from contaminated needles. These situations, when they occur, are life-threatening emergencies requiring prompt medical treatment. Physicians may recommend that allergic personnel continuing to work with laboratory animals carry a self-administered form of epinephrine (e.g., Epi-Pen® or Ana-Kit®) and instruct co-workers in emergency procedures. 

Animal Bites, Scratches, Kicks, etc.

 Animal bites, scratches, and kicks are ubiquitous hazards whenever working with animals, either in the laboratory, or in other locations. Most of these injuries, however, are easily preventable with proper training and the use of appropriate animal handling procedures. Knowledge of species-specific animal behavior is important in predicting and responding to the animal’s reaction. It is essential, both for the animals and for the human handlers, that each person be properly trained and proficient at handling the animals under their care. New personnel should be fully trained and instructed before handling animals. 

All personnel injured by animal bites, kicks, or scratches should immediately report the occurrence to their supervisor after the initial first aid procedures have been completed. All animal bites are potentially serious incidents because of the high potential for disease transmission and local infection from the animals contaminating oral flora. Medical attention should be sought in all but the most trivial injuries. 

Chemical Hazards 

A variety of chemicals are used in and around the animal facility including sterilants, disinfectants, alkaline and acid soaps, grease, insecticides, rodenticides, and various veterinary medical drugs, including volatile anesthetics. Proper handling of these chemicals is essential to prevent potential injury. Appropriate safety equipment including gloves, face protection, goggles, aprons, etc. should be worn whenever these chemicals are handled. Safety Data Sheets for all chemicals used should be readily available and preferably posted within the facility. 

The Occupational Safety and Health Administration (OSHA) has promulgated two important safety standards that have focused attention upon chemical risks to workers, the Hazard Communication Standard (29 CFR 1910.1200) and the Occupational Exposure to Hazardous Chemicals in Laboratories (29 CFR 1910.1450). Additionally, National Research Council’s Commission on Physical Sciences, Mathematics, and Applications (CPSMA) published Prudent Practices in the Laboratory: Handling and Disposal of Chemicals (National Academies Press, Inc., 1995) providing extensive discussion on hazard assessment and control. Many factors influence the potential risk associated with any chemical exposure. These include the toxicity of the chemical or the chemical mixture (mixtures may be more toxic than the single most toxic component), the dose of exposure, the duration and/or frequency of exposure, and the route of exposure. 

Flammability, corrosiveness, reactivity, and explosivity are generally well understood hazardous properties of chemicals. Toxicity is the least predictable and least understood property with the potential to cause immediate or delayed health effects. Chemicals handled in an animal research environment may be carcinogens, allergens, asphyxiants, corrosives, hepatotoxicants, irritants, mutagens, nephrotoxicants, neurotoxicants, and teratogens. Minimizing the exposure of personnel requires careful consideration of the routes of potential exposure that are associated with the animal care functions. Exposure routes include: (1) inhalation, (2) contact with skin or eyes, (3) ingestion, and (4) injection. 

(1) The types of chemical toxins can enter the body via inhalation include gases, the vapors of volatile liquids, mists and sprays of both volatile and nonvolatile liquid substances, and solid chemicals in the form of particles, fibers, and dusts. The toxic effects vary from local damage to the lungs or mucous membranes to rapid circulatory absorption and systemic effects. Particles may be sequestered in the lungs with serious delayed long-term effects. 

(2) Skin contact is a frequent mode of chemical exposure. Skin irritation and allergic skin reactions are a common result of contact with certain types of chemicals while corrosive chemicals can cause severe burns upon contact. In addition to causing local toxic effects, many chemicals are absorbed through the skin in sufficient quantity to produce systemic toxicity. 

Few substances are innocuous in contact with the eyes; most are painful and irritating, and a considerable number are capable of causing burns and loss of vision. Alkaline materials, phenols, and strong acids are particularly corrosive and can cause permanent loss of vision. 

(3) Many of the chemicals used in the laboratory are extremely hazardous if they are ingested. Caustic or irritating chemicals may produce lesions in the gastrointestinal tract tissues. Systemic toxicity requires the absorption of toxicants from the gastrointestinal tract into the circulation which may occur along the entire gastrointestinal tract, even in the mouth, and is dependent upon many factors, including the physical properties of the chemical and the speed at which it dissolves. 

(4) Exposure to toxic chemicals by injection is fortunately rare. It can occur directly during procedural administrations or inadvertently through mechanical injury from "sharps" such as glass or metal contaminated with chemicals or when chemicals are handled with syringes. Non-laboratory personnel, such as custodial workers or waste handlers, must be protected from this form of exposure by putting all "sharps" in special trash containers and never in the ordinary scrap baskets. 

Electricity

 Electrical hazards are present wherever current is flowing. Electrical hazards in animal facilities are often accentuated by frequently wet or damp surfaces and the presence of various electrically operated machines. The use of moisture resistant electrical covers and ground-fault interrupter circuits greatly reduces potential accidental electrical injuries. The use of appropriate operation lock-out and tag-out procedures when performing maintenance on equipment greatly reduces electrical shock risks. 

Ergonomic Hazards

 Animal care personnel are required to handle and manipulate heavy loads and bulky materials throughout the workday. Handling large loads improperly or performing repetitive tasks may result in chronic injuries. Proper procedures for handling all heavy loads should be practiced and safety equipment and load assistance equipment used to reduce potential injuries. Environmental Health and Safety provides training sessions on the proper procedures for handling heavy loads. Employees with existing physical handicaps or injuries should consult with the occupational health physician and their workday procedures should be altered to prevent additional injury. 

Health Precautions for Pregnant Personnel Working with Animals 

Pregnant employees or those planning to become pregnant should contact their obstetrician/gynecologist immediately and specify that they work with animals. The species and types of activities involved (e.g., work with a particular infectious agent, chemical hazard, inhalant anesthetic, radioisotope, etc.) should be discussed so that one becomes educated about the associated risks and precautionary measures.

Impaired Immune System 

Individuals with an impaired immune system, due to medication or disease, may be at a significantly greater risk of contracting an infectious disease from the animals with which they work. Such individuals should contact their personal physician and specify that they work with laboratory animals. One can also discuss this issue with the medical personnel associated with the OHSP who may, in turn, refer the enrollee to an occupational health physician. 

Ionizing Radiation 

Individuals are exposed to ionizing radiation on a daily basis as part of living on this planet (background radiation). Exposure to radiation in the animal care environment may result from irradiators, diagnostic veterinary x-rays, radioisotopes, and other sources. Appropriate procedures to minimize exposure and risk are based upon the type of radiation hazard and the possible methods of exposure. The use of ionizing radiation or radioisotopes is heavily regulated and under the oversight of Radiation Safety. The use of appropriate detection devices, personal protective equipment, and the use of proper procedures are all essential to minimize individual exposures and risks. 

Machinery and Equipment 

Tractors, tunnel washers, rack washers, autoclaves, pressure washers, floor polishers, compressed gas cylinders, etc., all pose potential risk to the operator or others if improperly used or maintained. Personnel using the equipment in the facility should be familiar with the proper procedures for use and follow standard procedures when using the equipment. Routine equipment maintenance is essential to ensure proper operation and minimal risk to the operator. The facility supervisor should be immediately notified if any piece of equipment is not functioning normally and the equipment should not be used until a determination of potential safety problems has been made. 

Noise

 Exposure to intense noise can and will result in impaired hearing. Chronic noise-induced hearing loss usually involves the higher pitched sounds, is permanent, and cannot be treated medically. The Occupational Safety and Health Administration limits employee exposure to noise to 90 decibels measured on the A scale of a standard sound-level meter at slow response (dBA) averaged over an 8-hour work shift (29 CFR 1910.95). Where levels exceed a time-weighted exposure of 85 dBA, the exposed employees need to participate in a hearing conservation program, administered through Environmental Health and Safety, that includes monitoring, audiometric testing, hearing protection, training, and record-keeping (29 CFR 1910.95 c-o). 

In animal facilities, excessive noise can result from animals (especially pigs and dogs), cage-washing equipment, heavy agricultural machinery, and other equipment operated in enclosed environments. The construction requirements for ease of sanitation in animal facilities often accentuate the level of noise since sound-deadening material is nearly absent. Environmental Health and Safety monitors and documents the noise levels in specific areas where concerns exist and, if the levels exceed permissible thresholds, warning signs are posted. In areas where high noise levels are known to be present, employees should avail themselves of noise-protection equipment and limit their time of occupancy in the area. 

Sharps 

Needles, broken glass, syringes, pipettes, scalpels, scissors, etc. are all common in laboratory animal facilities and pose a hazard to personnel. Everyone working with animals has a responsibility to know how to handle potentially dangerous objects and how to properly store these items. Used needles, syringes, and scalpels should be disposed of in “sharps” containers located throughout the facilities. Personnel using needles and syringes should use care in the procedures and not recap any needle without consideration of the potential hazard of a needle injury. Except in rare instances, needles should be disposed of uncapped. 

Zoonotic Diseases 

Zoonoses are infectious diseases capable of being transmitted from animals to humans. Program participants are educated (assigned reading) on species-specific zoonoses pertinent to the species with which they work. 

https://research.uky.edu/office-attending-veterinarian/zoonotic-diseases

Exposure Control Methods

UK controls exposures to stressors (occupational hazards) via the application of engineering controls, work practices, and the use of PPE.  During the EH&S review, any hazard mitigation is addressed utilizing the concept of the hierarchy of controls.  Every effort is employed to isolate personnel from hazards with engineering controls.  In the event engineering controls are not effective, personnel work practices are modified to mitigate hazard exposure.  PPE may be required to complement other controls. 

  • Chemical Fume Hoods 
    One of the primary hazard control mechanisms utilized within UK laboratories for the control of non-biological airborne hazards are chemical fume hoods.   At a minimum, EH&S performs a functional evaluation of every Chemical Fume Hood on an annual basis.  EH&S has established technical and performance standards that relate to the placement and functional operation of Chemical Fume Hoods.
     
  • Biological Safety Cabinets
    These control mechanisms are utilized within UK laboratories for the control of airborne biological hazards. EH&S has established policies and procedures related to the daily use, cleaning, decontamination, routine maintenance, and annual certification of Biological Safety Cabinets (BSCs).
     
  • Animal Transfer Stations 
    Animal Transfer Stations (ATSs) are utilized to contain particulate allergens when rodent caging is opened for routine husbandry or research activities. These units provide High Efficiency Particulate Air (HEPA) filtration of both the supply and exhaust air.  These units are designed for allergen control and provide much less restricted work area than BSCs. 
     
  • Individually Ventilated Caging Systems 
    These systems are utilized to provide containment of infectious agents as well as allergens.  The system cages are typically manipulated within a BSC.   The systems have an isolating capacity which protects both the housed animals and the working personnel via HEPA filtration of both supply and exhaust air which maintains cage integrity via self-closing valves when removed from rack.  Airflow within the individually ventilated cages provides a barrier which protects the animal as well as personnel from airborne infectious agents.
     
  • Cage Dumping Systems
    These systems are utilized to control airborne exposures to particulates during the removal of bedding from cages and incorporate the use of downdraft local exhaust systems or HEPA filtration.  No air from the local exhaust systems is recirculated -100 percent exhaust.
     
  • Scavenging Systems
    Where the use of a Chemical Fume Hood is not feasible, scavenging systems incorporating local exhaust ventilation or charcoal absorption are utilized.   These systems are utilized to prevent exposure to anesthetic agents.  
     
  • Work Practices/PPE
    All required work practices and PPE are identified and specified during the review of animal care and use protocols conducted by EH&S.  General work practices and PPE requirements are specified in the following:

For routine operations conducted within animal housing areas associated with animal husbandry and care, hazard assessments of tasks and training have been conducted in accordance with 29 CFR 1910.132.  This is inclusive of providing the required PPE as identified in the associated risk assessment.

Animals are transported through public areas to access laboratory space or to be transferred between animal facilities.  Rodents are transported through public areas in micro-isolator cages or shipping containers in a closed transport cart or on a laboratory cart completely covered with a drape. Animals and soiled equipment are transported between floors in freight elevators to avoid contact with individuals not associated with the animal care and use program. Animals other than rodents are transported in crates and the crates are covered with a drape. Soiled equipment is covered with drapes for transport outside of DLAR facilities.

Equipment Performance

Various types of engineering controls/systems are utilized to control exposures to affected personnel and protect the environment. Performance and operational integrity mechanisms have been implemented to ensure these controls/systems are providing the necessary protection and maintaining effective performance. Below are the various standard controls/systems utilized:

  • Chemical Fume Hoods 
    At a minimum, EH&S performs a functional evaluation of every Chemical Fume Hood on an annual basis.  EH&S has established technical and performance standards that relate to the placement and functional operation of Chemical Fume Hoods.  Evaluation and performance criteria are derived from ANSI/AIHA Z9.2-2012.

    All Chemical Fume Hoods are required to have face velocities between 80-120 feet per minute (fpm) with the sash at the designated working height. Working heights are most commonly 12 or 18 inches and are marked with a bright yellow chemical fume hood sticker indicating where the sash must be positioned and the measured face velocity.  Any chemical fume hood not meeting the minimum performance criteria is taken out of service and a sticker placed on the hood to warn personnel of its status and to seal the sash to prevent use. Operations requiring the use of the chemical fume hood are suspended until repairs can be made.
     
  • Biological Safety Cabinets
    UK has established and implemented policies and procedures related to the daily use, cleaning, decontamination, routine maintenance, and annual certification of BSCs. Only approved vendors may be utilized to certify, repair or decontaminate biological safety cabinets or laminar flow benches on the UK campus.
     
  • Animal Transfer Stations
    ATSs are certified every two years by an approved vendor to ensure design and performance standards are being met.  The certification includes HEPA filter replacement.
     
  • Individually Ventilated Caging Systems
    Performance monitoring and HEPA filter replacement is performed locally by DLAR staff.
     
  • Cage Dumping Systems
    Performance monitoring and filter replacement of the HEPA filtered local exhaust systems is performed locally by DLAR staff.   EH&S routinely monitors the performance of these units.
     
  • Scavenging Systems
    Activated charcoal scavenging canisters are replaced after 12 hours of use or after the canisters reach the designated maximum weight as stated by the manufacturer.  Depending on the location, the canisters are replaced by either DLAR staff or the investigator.
     
  • Autoclaves
    UK has established and implemented policies and procedures related to safe autoclave operation, installation of new autoclaves, routine preventive maintenance and repairs, appropriate signage, training and verification of autoclaves. These policies and procedures are best practice recommendations; however, specifics of daily use and routine maintenance shall be performed according to manufacturers’ recommendations. These policies and procedures apply to all laboratories at UK which generate biohazardous waste with the exception of laboratories operating at Biosafety Level 3.
     
  • Sanitary Wastewater Discharge Monitoring
    An Industrial User Wastewater Discharge Permit has been issued to UK from LFUCG (Lexington-Fayette Urban County Government) through authority from the Kentucky Division of Water and the US EPA as part of the Clean Water Act. This Permit authorizes discharge from UK to the city's sanitary sewer system through specifically permitted outfalls. The Permit requires semiannual monitoring events take place for several specific constituents as well as a calculation of corresponding flow rates all which must be reported to LFUCG on a semiannual basis.  All monitoring and reporting is performed by EH&S.
     
  • Room Ventilation
    All rooms where animals are housed have ventilation systems appropriate for the species and the type of animal use.
     
  • Fire/Life Safety Systems
    The UK Fire Marshal’s Office maintains information related to the status of each facility’s fire/life safety system and evacuation plan and inspects all fire extinguishers on an annual basis.  The systems inspection/testing listed below are conducted by the Physical Plant Division (PPD) or their designee.
    • Fire Alarm Inspection – performed by PPD per NFPA 72
    • Sprinkler System Inspection – performed by contractor per NFPA 13
    • Fire Pump Inspection – performed by contractor per NFPA 13
    • Emergency Lighting Testing – performed by PPD per KBC
    • Fire Escape Inspection – performed by contractor

Injury/Illness Reporting

All employees are required to report all job-related injuries or illnesses (Administrative Regulation 6:3 (PDF, 4pgs)). UK has established mechanisms for reporting all accidents, injuries or illnesses entitled Report Your Accident. To ensure compliance with NIH Guidelines for Recombinant DNA, UK has additionally established a reporting procedure for occupational injuries or exposures in laboratories (PDF, 2pgs).  Workers that sustain a work-related exposure, injury or illness are eligible for evaluation and care through Workers’ Compensation.  Workers shall be informed of their rights and how to file a Workers’ Compensation claim as part of their on boarding. The Workers’ Compensation claims adjuster will determine where the employee shall go for evaluation and treatment within their network.

Information Management

As part of its protocol review, EH&S communicates all hazard information related to chemical, physical, and biological stressors to personnel through Special Animal Safety Protocol (SASP) documents and hazardous agent awareness cage cards. The information communicated includes emergency contact information, characteristics of the agent and symptoms of exposure, minimum personal protective equipment (PPE) required, and required procedures, equipment, and disposal for working with animals exposed to these hazards. All SASP documents are available online to all personnel.

Online verification of safety training completion is available to all personnel including associated supervisors.

Additionally, EH&S analyzes and trends all injuries/illnesses that reported via the primary or secondary reporting procedure referenced in Report Your Accident.  Analyses and trends are shared with affected units to promote awareness and used by EH&S for targeting areas needing its services.

Emergency Procedures

Building Emergency Action Plans (BEAPs) have been established for all buildings with human occupancy and where animals are housed. The BEAP provides basic direction to all building occupants regarding the needed actions to take during an emergency or crisis. It also identifies building and floor coordinators who take the lead in creating and updating the plan. Additionally, they may assist in enacting required emergency procedures should the need arise.

References and Resources